Array BioPharma: Pfizer Closes Acquisition of Array BioPharma

Pfizer Inc. (NYSE:PFE) completed the previously announced acquisition of Array BioPharma Inc., advancing science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need. The deal amounted to $11.4 billion. As Array becomes part of Pfizer, it brings its existing portfolio that includes the [...]The post Pfizer Closes Acquisition of Array BioPharma appeared first on FinSMEs.